Cas:61019-17-8 2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide manufacturer & supplier

We serve Chemical Name:2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide CAS:61019-17-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide

Chemical Name:2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide
CAS.NO:61019-17-8
Synonyms:3-Thiophenecarboxamide,2-amino-5-(4-chlorophenyl)
Molecular Formula:C11H9ClN2OS
Molecular Weight:252.72000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:98.34000
Exact Mass:252.01200
LogP:4.21500

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Thiophenecarboxamide,2-amino-5-(4-chlorophenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Thiophenecarboxamide,2-amino-5-(4-chlorophenyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Thiophenecarboxamide,2-amino-5-(4-chlorophenyl) Use and application,3-Thiophenecarboxamide,2-amino-5-(4-chlorophenyl) technical grade,usp/ep/jp grade.


Related News: “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. 2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide manufacturer Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. 2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide vendor “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. 2-amino-5-(4-chlorophenyl)thiophene-3-carboxamide factory The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.